Here we provide a selection of scientific publications related to IOZK immunotherapy. You can use the filters to make a selection according to tumor types and methods, or enter search terms.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-10-01 / J. Immunother. 2015 Oct;38(8):330-9https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-10-01 / J. Immunother. 2015 Oct;38(8):330-92015-10-01 00:00:002019-02-15 08:51:17Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-10-01 / Nat. Med. 2015 Oct;21(10):1128-38https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-10-01 / Nat. Med. 2015 Oct;21(10):1128-382015-10-01 00:00:002015-10-01 00:00:00Natural and therapy-induced immunosurveillance in breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-09-15 / Oncotarget 2015 Sep;6(27):23462-79https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-09-15 / Oncotarget 2015 Sep;6(27):23462-792015-09-15 00:00:002019-02-15 08:52:37A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-09-14 / Int J Hyperthermia 2015;31(7):784-92https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-09-14 / Int J Hyperthermia 2015;31(7):784-922015-09-14 00:00:002019-03-27 11:37:15Electro-hyperthermia inhibits glioma tumorigenicity through the induction of E2F1-mediated apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-09-10 / Bioimpacts 2015;5(3):117-22https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-09-10 / Bioimpacts 2015;5(3):117-222015-09-10 00:00:002019-02-15 08:46:12A prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-09-01 / Cancer Biol Med 2015 Sep;12(3):201-8https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-09-01 / Cancer Biol Med 2015 Sep;12(3):201-82015-09-01 00:00:002019-02-15 08:35:54Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-08-27 / J. Neurooncol. 2015 Oct;125(1):65-74https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-08-27 / J. Neurooncol. 2015 Oct;125(1):65-742015-08-27 00:00:002019-02-15 08:47:20Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-08-27 / Biomed Res Int 2015;2015:842923https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-08-27 / Biomed Res Int 2015;2015:8429232015-08-27 00:00:002021-11-15 13:26:51Tumour Relapse Prediction Using Multiparametric MR Data Recorded during Follow-Up of GBM Patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-08-27 / 2016 Feb;5(2):e1078057https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-08-27 / 2016 Feb;5(2):e10780572015-08-27 00:00:002015-08-27 00:00:00Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer
Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy
Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma
Natural and therapy-induced immunosurveillance in breast cancer
Sensitivity of Human Malignant Melanoma Cell Lines to Newcastle Disease Virus
Immunotherapy for hepatocellular carcinoma
Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4
A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination
Electro-hyperthermia inhibits glioma tumorigenicity through the induction of E2F1-mediated apoptosis
Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
A prospective highlight on exosomal nanoshuttles and cancer immunotherapy and vaccination
Hyperthermia induces apoptosis by targeting Survivin in esophageal cancer
Immunotherapy of Brain Tumors
Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors
Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma
Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma
Tumour Relapse Prediction Using Multiparametric MR Data Recorded during Follow-Up of GBM Patients
Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer
HN Protein of Newcastle Disease Virus Induces Apoptosis Through SAPK/JNK Pathway
Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy
Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45)